Hong Kong-Based Consortium Reportedly To Buy Australian Fertility Treatment Provider For US$509M

Login to View

Tencent-backed healthcare firm WeDoctor Group, Hong Kong-listed financial services company Mason Group and Asian investment firm Aldworth Management will reportedly team up to acquire Australian fertility treatment firm Genea for an estimated HKD4 billion (about US$509 million), according to media reports.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info


Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in

China Money Network Subscription

RELATED NEWS